Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Medisyn Technologies logo — company profile

Medisyn Technologies

Founded 1999 United States Minnetonka, United States 2-10 employees Venture round Total: $1.50M Biotechnology, Health Care +1

General Information

Company Name Medisyn Technologies
Founded Year 1999
Location United States Minnetonka, United States
Founders / Decision Makers
Team member
Employees 2-10
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Medisyn Technologies. To contact Medisyn Technologies, visit medisyntech.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Medisyn Technologies compare?

A PDF of Medisyn Technologies and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Medisyn Technologies soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Medisyn Technologies

Medisyn Technologies is a biotechnology company founded in 1999, headquartered in the United States, specializing in bioactive compound design and discovery for pharmaceuticals, nutraceuticals, and animal health products. The company's proprietary Forward Engineering™ technology platform significantly expedites the bioactive compound discovery process, making it more predictable and cost-effective. Through molecular topology, Medisyn can design novel compounds in new chemical classes that meet specific therapeutic requirements, ultimately reducing the time for lead discovery from years to months. This approach not only minimizes risk but also enhances the likelihood of success and cost control for its customers. Medisyn Technologies secured a $1.50M Venture Round investment on 17 February 2005. The investors contributing to this round were Portage Equity Investments, StarTec Investments, MTI Ventures, Sherpa Partners, and Andcor Companies. The company operates within the biotechnology and healthcare industries, offering innovative solutions that could have wide-ranging implications for various health-related sectors.

Business keywords: bioactive compounds, drug discovery, pharmaceuticals, nutraceuticals, animal health products, cancer treatments, drug optimization, testing and analysis services, molecular topology, Forward Engineering™ technology, lead discovery process, biotech, agribusiness

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $1.50M 5
StarTec Investments MTI Ventures Sherpa Partners
StarTec Investments, MTI Ventures +3
17 Feb 2005

Medisyn Technologies Alternatives & Competitors

View All Alternatives
Medisyn Technologies vs
Merck & Co., Inc.
Merck & Co., Inc.

Merck develops and produces medicines, vaccines, biologic therapies and animal health products

IPO
92 employees
Biotechnology, Health Care
Medisyn Technologies vs
AC BioScience SA
AC BioScience SA Switzerland

AC BioScience is a biotech start-up committed to finding novel cancer treatments, based in Lausanne.

Seed
1 employees
Biotechnology, Health and Wellness
Medisyn Technologies vs
CrystalsFirst
CrystalsFirst Germany

Turning Insights Into Medicines

Non Equity Assistance
18 employees
AI, Biotechnology
View all alternatives

FAQ About Medisyn Technologies

Medisyn Technologies is a unique bioactive compound design and discovery company for novel pharmaceuticals, nutraceuticals and animal health products. Through its proprietary Forward Engineering™ technology platform, Medisyn makes bioactive compound discovery faster, more predictable and less expens...
Medisyn Technologies was founded in 1999.
Medisyn Technologies is headquartered in Minnetonka, United States.
Medisyn Technologies operates in Biotechnology, Health Care and Health and Wellness. Its work centres on bioactive compounds, drug discovery, pharmaceuticals and nutraceuticals.
Medisyn Technologies has approximately 2-10 employees.
Medisyn Technologies has completed 1 funding round, raising a total of $1.50M. The latest funding stage is Venture round.
Top alternatives and competitors to Medisyn Technologies include Merck & Co., Inc., AC BioScience SA, CrystalsFirst, BioPharmX, Sistemic Ltd. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Medisyn Technologies and Merck & Co., Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Medisyn Technologies, https://bouncewatch.com/company/medisyn-technologies, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout